Kodiak Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.

About KOD

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.

CEO

Victor Perlroth

CEOVictor Perlroth

Employees

111

Employees111

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2009

Founded2009

Employees

111

Employees111

KOD Key Statistics

Market cap

176.43M

Market cap176.43M

Price-Earnings ratio

-0.68

Price-Earnings ratio-0.68

Dividend yield

—

Dividend yield—

Average volume

566.34K

Average volume566.34K

High today

$3.56

High today$3.56

Low today

$3.30

Low today$3.30

Open price

$3.47

Open price$3.47

Volume

604.28K

Volume604.28K

52 Week high

$9.80

52 Week high$9.80

52 Week low

$1.37

52 Week low$1.37

Analyst ratings

43%

of 7 ratings

Buy

14.3%

Hold

42.9%

Sell

42.9%